Acadian Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,585,415
| Closed | -$8.6M | – | 1791 |
|
|
2024
Q4 | $8.6M | Buy |
1,585,415
+638,575
| +67% | +$3.47M | 0.03% | 395 |
|
|
2024
Q3 | $6.83M | Buy |
946,840
+946,254
| +161,477% | +$6.83M | 0.02% | 418 |
|
|
2024
Q2 | $6K | Buy |
+586
| New | +$6K | ﹤0.01% | 1714 |
|
|
2022
Q2 | – | Sell |
-180,979
| Closed | -$5.99M | – | 1829 |
|
|
2022
Q1 | $5.99M | Sell |
180,979
-276,601
| -60% | -$9.15M | 0.02% | 426 |
|
|
2021
Q4 | $19.5M | Buy |
457,580
+78,335
| +21% | +$3.33M | 0.07% | 210 |
|
|
2021
Q3 | $16.8M | Buy |
379,245
+177,102
| +88% | +$7.85M | 0.06% | 230 |
|
|
2021
Q2 | $11.5M | Buy |
202,143
+109,093
| +117% | +$6.2M | 0.04% | 302 |
|
|
2021
Q1 | $6.97M | Buy |
93,050
+92,691
| +25,819% | +$6.94M | 0.03% | 395 |
|
|
2020
Q4 | $31K | Buy |
+359
| New | +$31K | ﹤0.01% | 2061 |
|
|
2020
Q3 | – | Sell |
-614
| Closed | -$26K | – | 2330 |
|
|
2020
Q2 | $26K | Buy |
+614
| New | +$26K | ﹤0.01% | 2082 |
|